NESTAL BioSciences Inc.

About Us

NESTAL BioSciences Inc. is dedicated to revolutionizing the medical sector through the development and commercialization of cutting-edge innovations from academia, government and industry that enhance patient outcomes and improve quality of life and create value for shareholders and stakeholders. The company is focused on becoming a leader in the sector driving innovation, leveraging resources, partnerships, collaborations and associations to deliver value to patients, healthcare providers, and shareholders.


Our Mission is to revolutionize segments we pursue through innovative, safe, and affordable solutions that enhance healing and improve quality of life for patients, while empowering healthcare providers and payers with the knowledge and tools needed for positive outcomes. We are committed to collaboration, innovation, and excellence to drive positive change in the wound care market.


Our Vision is to lead the way in innovative and effective wound care solutions, empowering patients and improving outcomes. We strive to make the best possible care accessible to everyone, enabling faster, more effective, and less painful healing. Our cutting-edge technology and deep commitment to excellence are paving the way for a brighter future in wound care.

Product:

Smart Stim™ is novel, see-through, e-stim technology that does not stick to the wound, accelerates healing while allowing visual assessment without removal and remote monitoring capabilities.

The Smart Stim™ Technology

Embedded with electrodes that stimulate healing [angiogenesis/blood vessel growth/vascularization]
Transparent [see-through] without removal.
Moist absorbent layer = helps healing.
Faster healing @20% or more.
Sensors - remote monitoring.

Use Cases

Smart Stim™ Technology is ideally suited for patients with chronic wounds including:

diabetic wounds
pressure ulcers
bed sores
venous ulcers
arterial ulcers
surgical wounds

Our Partners

Team

Tal Lally

CEO

BSc Marketing/Pharmaceutical Sciences - 20+ years in therapeutics and medical devices with planning and execution of sales and marketing strategies. Experienced clinical influencer developer, KOL's, physicians, nurses, and other healthcare stakeholders to drive adoption.  Part of therapeutics launch team generating over $1B in revenue. Managing cross -functional teams, including R&D, medical affairs, engineering, and marketing.

Roger Anderson

COO

Roger Anderson, Ph.D., 26+ years Operations, Sales, and as CEO, COO in med device, lab supplies and software. His skill sets are deep in new business/new markets, consulting, life science, operations, biotech, IT, healthcare and software companies. Roger increased sales for Immunobiologics Div. of MP Biomedicals (ICN Biomedicals), by over 200% in less than two years.

James Nesbitt

CRO

James Nesbitt, LLB, General Counsel, CRO and Director. Participant with FEMA/DHS/HHS Committee DPA708 National Multimodal Healthcare Supply, Manufacturing, importing and supply. Compliance with the Federal Acquisition Regulations. System Award Management, Defense Logistics Agency, DAL - NATO, FEMA, CBRN, HHS, FDA and other government agencies. He significantly assists in MNE strategies to ensure market presence and global reach. He is a co-registrant on a number of SME and MNE companies under the UN Global Compact and UN Global Marketplace.

Kath Bogie

CTO & Advisor

Ph.D. Oxford, Biomedical Engineer. Research Career Scientist, Louis Stokes Cleveland VA Medical Center and Professor, Department of Orthopedics, Case Western Reserve University. Dr. Bogie has an international reputation in translational research and leads interdisciplinary teams to develop patient-centered interventions that meet the complex, multi-factorial problems of wound management.

Anya Roberts

Scientific commercialization advisor

Ph.D. MIT, Biomedical Engineer, head of corporate technology discovery at Fedtech. She is a Fulbright Research Fellow, National Science Foundation and DoD National Defense Science and Engineering. Focused on new venture formation, strategy at the intersection of business and science, and the evolution of entrepreneurial ecosystems. Her interdisciplinary research focuses on the biomechanics and resulting genetic alterations of tumor cells as they spread through the body, biological engineering, and physics.

 
Technical Advisor





Contact Us

Wilmington DE 19801

Las Vegas NV 89193

info[at]nestalbio.com

302-404-6506